ARCHIVES

Study of Dlurectic Use As Renal Cell Cancer Risk Gets Concept Approval

This article is from The Cancer Letter archive.

Vol. 15 No. 11 | March 10, 1989

Download PDF Visit The Full Archive

Related Articles

NHLBI Advisers Commit Funding TO NCI’s Women’s Health Trials, Tamoxifen Trial

March 8, 1991

ETP-ALL May Be Linked To Acute Myeloid Leukemia

January 27, 2012

Four New Program Announcements For BRMP Trials Issued

October 22, 1982

DCE Advisors Approve New Epidemiology RFPs Table Proposed RFA

April 16, 1993

Simmonds Succeeds Young As ACS President; Lame-Duck Session Unlikely To Approve Funding Bills

November 8, 2002

Two Papers Evaluate CyberKnife Survival Rates and Tolerability

November 29, 2013